{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Inflammation", "Insulin", "Oxidative stress", "Peroxisome proliferator-activated receptor-\u03b3", "Sulforaphane", "Type 2 diabetes"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "37955784", "DateCompleted": {"Year": "2023", "Month": "12", "Day": "04"}, "DateRevised": {"Year": "2023", "Month": "12", "Day": "17"}, "Article": {"ArticleDate": [{"Year": "2023", "Month": "11", "Day": "13"}], "Language": ["eng"], "ELocationID": ["10.1007/s10787-023-01373-z"], "Journal": {"ISSN": "1568-5608", "JournalIssue": {"Volume": "31", "Issue": "6", "PubDate": {"Year": "2023", "Month": "Dec"}}, "Title": "Inflammopharmacology", "ISOAbbreviation": "Inflammopharmacology"}, "ArticleTitle": "A mechanistic overview of sulforaphane and its derivatives application in diabetes and its complications.", "Pagination": {"StartPage": "2885", "EndPage": "2899", "MedlinePgn": "2885-2899"}, "Abstract": {"AbstractText": ["Sulforaphane (SFN) is a type of phytochemical found in many cruciferous vegetables that has been shown to positively benefit the control of Type 2 Diabetes Mellitus (T2DM). The search was done from 2000 until December 2022 using PubMed, Scopus, Web of Sciences, and Google Scholar databases. We included all in vitro, in vivo, and clinical trials. Sulforaphane has been demonstrated to activate the PI<sub>3</sub>K/AKT and AMP-activated protein kinase pathways and the glucose transporter type 4 to increase insulin production and reduce insulin resistance. Interestingly, SFN possesses protective effects against diabetes complications, such as diabetic-induced hepatic damage, vascular inflammation and endothelial dysfunction, nephropathy, and neuropathy via nuclear factor erythroid 2-related factor 2 activation that leads to the translation of several anti-oxidant enzymes and regulation glycolysis, pentose phosphate pathway, fatty acid metabolism, glutamine metabolism, and glutathione metabolism. Furthermore, multiple clinical trial studies emphasized the ameliorating effects of SFN on T2DM patients. This review provides sufficient evidence for further research and development of sulforaphane as a hypoglycemic drug."], "CopyrightInformation": "\u00a9 2023. The Author(s), under exclusive licence to Springer Nature Switzerland AG."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Herbal and Traditional Medicine Research Center, Kerman University of Medical Sciences, Kerman, Iran."}], "LastName": "Mohamadi", "ForeName": "Neda", "Initials": "N"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Cardiovascular Diseases, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran."}], "LastName": "Baradaran Rahimi", "ForeName": "Vafa", "Initials": "V"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutics, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran."}], "LastName": "Fadaei", "ForeName": "Mohammad Reza", "Initials": "MR"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Research Center of Tropical and Infectious Diseases, Kerman University of Medical Sciences, Kerman, Iran. fatemeh7267@gmail.com."}], "LastName": "Sharifi", "ForeName": "Fatemeh", "Initials": "F"}, {"Identifier": ["0000-0001-9268-6270"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Pharmacological Research Center of Medicinal Plants, Mashhad University of Medical Sciences, Mashhad, Iran. askariv@mums.ac.ir."}, {"Identifier": [], "Affiliation": "Applied Biomedical Research Center, Mashhad University of Medical Sciences, Mashhad, Iran. askariv@mums.ac.ir."}], "LastName": "Askari", "ForeName": "Vahid Reza", "Initials": "VR"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Inflammopharmacology", "NlmUniqueID": "9112626", "ISSNLinking": "0925-4692"}, "ChemicalList": [{"RegistryNumber": "GA49J4310U", "NameOfSubstance": "sulforaphane"}, {"RegistryNumber": "0", "NameOfSubstance": "Antioxidants"}, {"RegistryNumber": "0", "NameOfSubstance": "Isothiocyanates"}, {"RegistryNumber": "0", "NameOfSubstance": "NF-E2-Related Factor 2"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["drug therapy", "metabolism"], "DescriptorName": "Diabetes Mellitus, Type 2"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Diabetes Mellitus, Experimental"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Antioxidants"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Isothiocyanates"}, {"QualifierName": ["metabolism"], "DescriptorName": "NF-E2-Related Factor 2"}, {"QualifierName": [], "DescriptorName": "Oxidative Stress"}]}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Axelsson AS, Tubbs E, Mecham B, Chacko S, Nenonen HA, Tang Y et al (2017) Sulforaphane reduces hepatic glucose production and improves glucose control in patients with type 2 diabetes. Sci Transl Med 9(394):eaah4477", "ArticleIdList": ["28615356", "10.1126/scitranslmed.aah4477"]}, {"Citation": "Bahadoran Z, Mirmiran P, Hosseinpanah F, Hedayati M, Hosseinpour-Niazi S, Azizi F (2011) Broccoli sprouts reduce oxidative stress in type 2 diabetes: a randomized double-blind clinical trial. Eur J Clin Nutr 65(8):972\u2013977", "ArticleIdList": ["21559038", "10.1038/ejcn.2011.59"]}, {"Citation": "Bahadoran Z, Mirmiran P, Hosseinpanah F, Rajab A, Asghari G, Azizi F (2012a) Broccoli sprouts powder could improve serum triglyceride and oxidized LDL/LDL-cholesterol ratio in type 2 diabetic patients: a randomized double-blind placebo-controlled clinical trial. Diabetes Res Clin Pract 96(3):348\u2013354", "ArticleIdList": ["22325157", "10.1016/j.diabres.2012.01.009"]}, {"Citation": "Bahadoran Z, Tohidi M, Nazeri P, Mehran M, Azizi F, Mirmiran P (2012b) Effect of broccoli sprouts on insulin resistance in type 2 diabetic patients: a randomized double-blind clinical trial. Int J Food Sci Nutr 63(7):767\u2013771", "ArticleIdList": ["22537070", "10.3109/09637486.2012.665043"]}, {"Citation": "Bahadoran Z, Mirmiran P, Azizi F (2013) Potential efficacy of broccoli sprouts as a unique supplement for management of type 2 diabetes and its complications. J Med Food 16(5):375\u2013382", "ArticleIdList": ["23631497", "10.1089/jmf.2012.2559"]}, {"Citation": "Bai Y, Cui W, Xin Y, Miao X, Barati MT, Zhang C et al (2013) Prevention by sulforaphane of diabetic cardiomyopathy is associated with up-regulation of Nrf2 expression and transcription activation. J Mol Cell Cardiol 57:82\u201395", "ArticleIdList": ["23353773", "10.1016/j.yjmcc.2013.01.008"]}, {"Citation": "Bai Y, Wang X, Zhao S, Ma C, Cui J, Zheng Y (2015) Sulforaphane protects against cardiovascular disease via Nrf2 activation. Oxid Med Cell Longev 2015:1", "ArticleIdList": ["10.1155/2015/407580"]}, {"Citation": "Baradaran Rahimi V, Rajabian A, Rajabi H, Mohammadi Vosough E, Mirkarimi HR, Hasanpour M et al (2020) The effects of hydro-ethanolic extract of Capparis spinosa (C. spinosa) on lipopolysaccharide (LPS)-induced inflammation and cognitive impairment: evidence from in vivo and in vitro studies. J Ethnopharmacol 256:112706. https://doi.org/10.1016/j.jep.2020.112706", "ArticleIdList": ["10.1016/j.jep.2020.112706", "32109547"]}, {"Citation": "Basha SC, Babu KR, Madhu M, Gopinath C (2017) In vitro antidiabetic activity of sulforaphane. Pharmacol Toxicol Biomed Rep 3(2):47", "ArticleIdList": ["10.5530/PTB.2017.3.9"]}, {"Citation": "Bernuzzi F, Maertens A, Saha S, Troncoso-Rey P, Ludwig T, Hiller K et al (2023) Sulforaphane rewires central metabolism to support antioxidant response and achieve glucose homeostasis. Redox Biol J 67:102878", "ArticleIdList": ["10.1016/j.redox.2023.102878"]}, {"Citation": "Betz C, Stracka D, Prescianotto-Baschong C, Frieden M, Demaurex N, Hall MN (2013) mTOR complex 2-Akt signaling at mitochondria-associated endoplasmic reticulum membranes (MAM) regulates mitochondrial physiology. Proc Natl Acad Sci 110(31):12526\u201312534", "ArticleIdList": ["23852728", "3732980", "10.1073/pnas.1302455110"]}, {"Citation": "Cole JB, Florez JC (2020) Genetics of diabetes mellitus and diabetes complications. Nat Rev Nephrol 16(7):377\u2013390. https://doi.org/10.1038/s41581-020-0278-5", "ArticleIdList": ["10.1038/s41581-020-0278-5", "32398868", "9639302"]}, {"Citation": "Corssac GB, Campos-Carraro C, Hickmann A, da Rosa Araujo AS, Fernandes RO, Bell\u00f3-Klein AJB et al (2018) Sulforaphane effects on oxidative stress parameters in culture of adult cardiomyocytes. Biomed Pharmcother 104:165\u2013171", "ArticleIdList": ["10.1016/j.biopha.2018.05.031"]}, {"Citation": "Cui W, Bai Y, Miao X, Luo P, Chen Q, Tan Y et al (2012) Prevention of diabetic nephropathy by sulforaphane: possible role of Nrf2 upregulation and activation. Oxid Med Cell Longev 2012:1", "ArticleIdList": ["10.1155/2012/821936"]}, {"Citation": "de Souza CG, Sattler JA, de Assis AM, Rech A, Perry MLS, Souza DO (2012) Metabolic effects of sulforaphane oral treatment in streptozotocin-diabetic rats. J Med Food 15(9):795\u2013801", "ArticleIdList": ["22925073", "10.1089/jmf.2012.0016"]}, {"Citation": "Fuentes F, Paredes-Gonzalez X, Kong A-NT (2015) Dietary glucosinolates sulforaphane, phenethyl isothiocyanate, indole-3-carbinol/3, 3\u2032-diindolylmethane: antioxidative stress/inflammation, Nrf2, epigenetics/epigenomics and in vivo cancer chemopreventive efficacy. Curr Pharmacol Rep 1(3):179\u2013196", "ArticleIdList": ["26457242", "4596548", "10.1007/s40495-015-0017-y"]}, {"Citation": "He F, Ru X, Wen T (2020) NRF2, a transcription factor for stress response and beyond. Int J Mol Sci 21(13):4777", "ArticleIdList": ["32640524", "7369905", "10.3390/ijms21134777"]}, {"Citation": "Jiang X, Bai Y, Zhang Z, Xin Y, Cai L (2014) Protection by sulforaphane from type 1 diabetes-induced testicular apoptosis is associated with the up-regulation of Nrf2 expression and function. Toxicol Appl Pharmacol 279(2):198\u2013210", "ArticleIdList": ["24967692", "10.1016/j.taap.2014.06.009"]}, {"Citation": "Kayama Y, Raaz U, Jagger A, Adam M, Schellinger IN, Sakamoto M et al (2015) Diabetic cardiovascular disease induced by oxidative stress. Int J Mol Sci 16(10):25234\u201325263", "ArticleIdList": ["26512646", "4632800", "10.3390/ijms161025234"]}, {"Citation": "Kensler TW, Chen J-G, Egner PA, Fahey JW, Jacobson LP, Stephenson KK et al (2005) Effects of glucosinolate-rich broccoli sprouts on urinary levels of aflatoxin-DNA adducts and phenanthrene tetraols in a randomized clinical trial in He Zuo township, Qidong, People\u2019s Republic of China. Cancer Epidemiol Biomark Prev 14(11):2605\u20132613", "ArticleIdList": ["10.1158/1055-9965.EPI-05-0368"]}, {"Citation": "Khaleel SA, Raslan NA, Alzokaky AA, Ewees MG, Ashour AA, Abdel-Hamied HE et al (2019) Contrast media (meglumine diatrizoate) aggravates renal inflammation, oxidative DNA damage and apoptosis in diabetic rats which is restored by sulforaphane through Nrf2/HO-1 reactivation. Chem Biol Interact 309:108689", "ArticleIdList": ["31173751", "10.1016/j.cbi.2019.06.002"]}, {"Citation": "Klomparens EA, Ding Y (2019) The neuroprotective mechanisms and effects of sulforaphane. Brain Circ 5(2):74", "ArticleIdList": ["31334360", "6611193", "10.4103/bc.bc_7_19"]}, {"Citation": "Kong L, Wang H, Li C, Cheng H, Cui Y, Liu L et al (2021) Sulforaphane ameliorates diabetes-induced renal fibrosis through epigenetic up-regulation of BMP-7. Diabetes Metab J 45(6):909\u2013920", "ArticleIdList": ["34082508", "8640156", "10.4093/dmj.2020.0168"]}, {"Citation": "Langston-Cox A, Anderson D, Creek DJ, Palmer K, Wallace EM, Marshall SA (2020) Measuring sulforaphane and its metabolites in human plasma: a high throughput method. Molecules 25(4):829", "ArticleIdList": ["32070059", "7070302", "10.3390/molecules25040829"]}, {"Citation": "Lee JH, Sarker MK, Choi H, Shin D, Kim D, Jun H-S (2019) Lysophosphatidic acid receptor 1 inhibitor, AM095, attenuates diabetic nephropathy in mice by downregulation of TLR4/NF-\u03baB signaling and NADPH oxidase. Biochim Biophys Acta Mol Basis Dis 1865(6):1332\u20131340", "ArticleIdList": ["30763641", "10.1016/j.bbadis.2019.02.001"]}, {"Citation": "Li S, Yang H, Chen X (2019) Protective effects of sulforaphane on diabetic retinopathy: activation of the Nrf2 pathway and inhibition of NLRP3 inflammasome formation. Exp Anim 68(2):221\u2013231", "ArticleIdList": ["30606939", "6511524", "10.1538/expanim.18-0146"]}, {"Citation": "Li Z, Guo H, Li J, Ma T, Zhou S, Zhang Z et al (2020) Sulforaphane prevents type 2 diabetes-induced nephropathy via AMPK-mediated activation of lipid metabolic pathways and Nrf2 antioxidative function. Clin Sci 134(18):2469\u20132487", "ArticleIdList": ["10.1042/CS20191088"]}, {"Citation": "Lin C-F, Chueh T-H, Chung C-H, Chung S-D, Chang T-C, Chien C-T (2020) Sulforaphane improves voiding function via the preserving mitochondrial function in diabetic rats. J Formos Med Assoc 119(9):1422\u20131430", "ArticleIdList": ["31837923", "10.1016/j.jfma.2019.11.017"]}, {"Citation": "Liu D, Wang A, Liu J, Alkhalidy H, Zhen W, Moore W (2017) Genistein in combination with sulforaphane for the treatment of type 2 diabetes. FASEB J 31:646.51-646.51", "ArticleIdList": ["10.1096/fasebj.31.1_supplement.646.51"]}, {"Citation": "Lv J, Bao S, Liu T, Wei L, Wang D, Ye W et al (2020a) Sulforaphane delays diabetes-induced retinal photoreceptor cell degeneration. Cell Tissue Res 382:477\u2013486", "ArticleIdList": ["32783101", "10.1007/s00441-020-03267-w"]}, {"Citation": "Maiese K (2015) New insights for oxidative stress and diabetes mellitus. Oxid Med Cell Longev"}, {"Citation": "Miao X, Bai Y, Sun W, Cui W, Xin Y, Wang Y et al (2012) Sulforaphane prevention of diabetes-induced aortic damage was associated with the up-regulation of Nrf2 and its down-stream antioxidants. Nutr Metabol 9(1):1\u20139", "ArticleIdList": ["10.1186/1743-7075-9-84"]}, {"Citation": "Mirmiran P, Bahadoran Z, Hosseinpanah F, Keyzad A, Azizi F (2012) Effects of broccoli sprout with high sulforaphane concentration on inflammatory markers in type 2 diabetic patients: a randomized double-blind placebo-controlled clinical trial. J Funct Foods 4(4):837\u2013841", "ArticleIdList": ["10.1016/j.jff.2012.05.012"]}, {"Citation": "Moustafa PE, Abdelkader NF, El Awdan SA, El-Shabrawy OA, Zaki HF (2018) Extracellular matrix remodeling and modulation of inflammation and oxidative stress by sulforaphane in experimental diabetic peripheral neuropathy. Inflammation 41(4):1460\u20131476", "ArticleIdList": ["29704151", "10.1007/s10753-018-0792-9"]}, {"Citation": "Negi G, Kumar A, Sharma S, S. (2011) Nrf2 and NF-\u03baB modulation by sulforaphane counteracts multiple manifestations of diabetic neuropathy in rats and high glucose-induced changes. Curr Neurovasc Res 8(4):294\u2013304", "ArticleIdList": ["22023613", "10.2174/156720211798120972"]}, {"Citation": "Patel B, Mann GE, Chapple SJJ (2018) Concerted redox modulation by sulforaphane alleviates diabetes and cardiometabolic syndrome. Free Rad Biol Med 122:150\u2013160", "ArticleIdList": ["29427794", "10.1016/j.freeradbiomed.2018.02.004"]}, {"Citation": "Pereira A, Fernandes R, Cris\u00f3stomo J, Sei\u00e7a RM, Sena CM (2017) The Sulforaphane and pyridoxamine supplementation normalize endothelial dysfunction associated with type 2 diabetes. Sci Rep 7(1):1\u201313", "ArticleIdList": ["10.1038/s41598-017-14733-x"]}, {"Citation": "Pu D, Zhao Y, Chen J, Lv A, Zhu S, Luo C et al (2018) Protective effects of sulforaphane on cognitive impairments and AD-like lesions in diabetic mice are associated with the upregulation of Nrf2 transcription activity. Neuroscience 381:35\u201345", "ArticleIdList": ["29684505", "10.1016/j.neuroscience.2018.04.017"]}, {"Citation": "Rodriguez BL, Abbott RD, Fujimoto W, Waitzfelder B, Chen R, Masaki K et al (2002) The American Diabetes Association and World Health Organization classifications for diabetes: their impact on diabetes prevalence and total and cardiovascular disease mortality in elderly Japanese-American men. J Diabetes Care 25(6):951\u2013955", "ArticleIdList": ["10.2337/diacare.25.6.951"]}, {"Citation": "Safiri S, Karamzad N, Kaufman JS, Bell AW, Nejadghaderi SA, Sullman MJ et al (2022) Prevalence, deaths and disability-adjusted-life-years (dalys) due to type 2 diabetes and its attributable risk factors in 204 countries and territories, 1990\u20132019: results from the global burden of disease study 2019. Front Endocrinol 13:838027", "ArticleIdList": ["10.3389/fendo.2022.838027"]}, {"Citation": "Shang G, Tang X, Gao P, Guo F, Liu H, Zhao Z et al (2015a) Sulforaphane attenuation of experimental diabetic nephropathy involves GSK-3 beta/Fyn/Nrf2 signaling pathway. J Nutr Biochem 26(6):596\u2013606", "ArticleIdList": ["25724107", "10.1016/j.jnutbio.2014.12.008"]}, {"Citation": "Shawky NM, Shehatou GS, Suddek GM, Gameil NM (2019) Comparison of the effects of sulforaphane and pioglitazone on insulin resistance and associated dyslipidemia, hepatosteatosis, and endothelial dysfunction in fructose-fed rats. Environ Toxicol Pharmacol 66:43\u201354", "ArticleIdList": ["30597379", "10.1016/j.etap.2018.12.008"]}, {"Citation": "Song M-Y, Kim E-K, Moon W-S, Park J-W, Kim H-J, So H-S et al (2009) Sulforaphane protects against cytokine-and streptozotocin-induced \u03b2-cell damage by suppressing the NF-\u03baB pathway. Toxicol Appl Pharmacol 235(1):57\u201367", "ArticleIdList": ["19071154", "10.1016/j.taap.2008.11.007"]}, {"Citation": "Sun Y, Yang T, Mao L, Zhang F (2017) Sulforaphane protects against brain diseases: roles of cytoprotective enzymes. Austin J Cerebrovasc Dis Stroke 4(1)"}, {"Citation": "Sun Y, Zhou S, Guo H, Zhang J, Ma T, Zheng Y et al (2020) Protective effects of sulforaphane on type 2 diabetes-induced cardiomyopathy via AMPK-mediated activation of lipid metabolic pathways and NRF2 function. Metabolism 102:154002", "ArticleIdList": ["31706979", "10.1016/j.metabol.2019.154002"]}, {"Citation": "Tang L, Ren X, Han Y, Chen L, Meng X, Zhang C et al (2020) Sulforaphane attenuates apoptosis of hippocampal neurons induced by high glucose via regulating endoplasmic reticulum. Neurochem Int 136:104728", "ArticleIdList": ["32199985", "10.1016/j.neuint.2020.104728"]}, {"Citation": "Taniguchi CM, Ueki K, Kahn CRJTJ (2005) Complementary roles of IRS-1 and IRS-2 in the hepatic regulation of metabolism. J Clin Investig 115(3):718\u2013727", "ArticleIdList": ["15711641", "548317", "10.1172/JCI23187"]}, {"Citation": "Tarozzi A, Angeloni C, Malaguti M, Morroni F, Hrelia S, Hrelia P (2013) Sulforaphane as a potential protective phytochemical against neurodegenerative diseases. Oxid Med Cell Longev"}, {"Citation": "Tian S, Li X, Wang Y, Lu Y (2021) The protective effect of sulforaphane on type II diabetes induced by high-fat diet and low-dosage streptozotocin. Food Sci Nutr Metabol 9(2):747\u2013756", "ArticleIdList": ["10.1002/fsn3.2040"]}, {"Citation": "Tubbs E, Axelsson AS, Vial G, Wollheim CB, Rieusset J, Rosengren AH (2018) Sulforaphane improves disrupted ER-mitochondria interactions and suppresses exaggerated hepatic glucose production. Mol Cell Endocrinol 461:205\u2013214", "ArticleIdList": ["28923347", "10.1016/j.mce.2017.09.016"]}, {"Citation": "Wang Y, Zhang Z, Guo W, Sun W, Miao X, Wu H et al (2014) Sulforaphane reduction of testicular apoptotic cell death in diabetic mice is associated with the upregulation of Nrf2 expression and function. Am J Physiol-Endocrinol Metabol 307(1):E14\u2013E23", "ArticleIdList": ["10.1152/ajpendo.00702.2013"]}, {"Citation": "Wang G, Fang H, Zhen Y, Xu G, Tian J, Zhang Y et al (2016) Sulforaphane prevents neuronal apoptosis and memory impairment in diabetic rats. Cell Physiol Biochem 39(3):901\u2013907", "ArticleIdList": ["27497670", "10.1159/000447799"]}, {"Citation": "Wang J, Wang S, Wang W, Chen J, Zhang Z, Zheng Q et al (2019) Protection against diabetic cardiomyopathy is achieved using a combination of sulforaphane and zinc in type 1 diabetic OVE26 mice. J Cell Mol Med 23(9):6319\u20136330", "ArticleIdList": ["31270951", "6714218", "10.1111/jcmm.14520"]}, {"Citation": "Wang M, Pu D, Zhao Y, Chen J, Zhu S, Lu A et al (2020) Sulforaphane protects against skeletal muscle dysfunction in spontaneous type 2 diabetic db/db mice. Life Sci 255:117823", "ArticleIdList": ["32445760", "10.1016/j.lfs.2020.117823"]}, {"Citation": "Wang M, Chen M, Guo R, Ding Y, Zhang H, He Y (2022) The improvement of sulforaphane in type 2 diabetes mellitus (T2DM) and related complications: a review. Trends Food Sci Technol 129:397", "ArticleIdList": ["10.1016/j.tifs.2022.10.007"]}, {"Citation": "Wang Y, Xu Y, Wang Q, Guo F, Song Y, Fan X et al (2023) Sulforaphane ameliorated podocyte injury according to regulation of the Nrf2/PINK1 pathway for mitophagy in diabetic kidney disease. Eur J Pharmacol 958:176042", "ArticleIdList": ["37660971", "10.1016/j.ejphar.2023.176042"]}, {"Citation": "Wu H, Kong L, Cheng Y, Zhang Z, Wang Y, Luo M et al (2015) Metallothionein plays a prominent role in the prevention of diabetic nephropathy by sulforaphane via up-regulation of Nrf2. Free Rad Biol Med 89:431\u2013442", "ArticleIdList": ["26415026", "10.1016/j.freeradbiomed.2015.08.009"]}, {"Citation": "Xu Y, Fu J-F, Chen J-H, Zhang Z-W, Zou Z-Q, Han L-Y et al (2018) Sulforaphane ameliorates glucose intolerance in obese mice via the upregulation of the insulin signaling pathway. Food Funct 9(9):4695\u20134701", "ArticleIdList": ["30091431", "10.1039/C8FO00763B"]}, {"Citation": "Zhang Z, Wang S, Zhou S, Yan X, Wang Y, Chen J et al (2014) Sulforaphane prevents the development of cardiomyopathy in type 2 diabetic mice probably by reversing oxidative stress-induced inhibition of LKB1/AMPK pathway. J Mol Cell Cardiol 77:42\u201352", "ArticleIdList": ["25268649", "10.1016/j.yjmcc.2014.09.022"]}, {"Citation": "Zhang HQ, Chen SY, Wang AS, Yao AJ, Fu JF, Zhao JS et al (2016) Sulforaphane induces adipocyte browning and promotes glucose and lipid utilization. Mol Nutr Food Res 60(10):2185\u20132197", "ArticleIdList": ["27218607", "5111775", "10.1002/mnfr.201500915"]}, {"Citation": "Zhang Y, Wu Q, Liu J, Zhang Z, Ma X, Zhang Y et al (2022) Sulforaphane alleviates high fat diet-induced insulin resistance via AMPK/Nrf2/GPx4 axis. Biomed Pharmacother 152:113273", "ArticleIdList": ["35709656", "10.1016/j.biopha.2022.113273"]}, {"Citation": "Zhou Q, Chen B, Wang X, Wu L, Yang Y, Cheng X et al (2016) Sulforaphane protects against rotenone-induced neurotoxicity in vivo: Involvement of the mTOR, Nrf2 and autophagy pathways. Sci Rep 6(1):1\u201312"}], "ReferenceList": []}], "History": [{"Year": "2023", "Month": "7", "Day": "7"}, {"Year": "2023", "Month": "10", "Day": "9"}, {"Year": "2023", "Month": "12", "Day": "4", "Hour": "12", "Minute": "42"}, {"Year": "2023", "Month": "11", "Day": "13", "Hour": "12", "Minute": "41"}, {"Year": "2023", "Month": "11", "Day": "13", "Hour": "11", "Minute": "10"}], "PublicationStatus": "ppublish", "ArticleIdList": ["37955784", "10.1007/s10787-023-01373-z", "10.1007/s10787-023-01373-z"]}}], "PubmedBookArticle": []}